Global Spinal Muscular Atrophy Medicine Market Insights and Forecast to 2026

Global Spinal Muscular Atrophy Medicine Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Spinal Muscular Atrophy Medicine Product Introduction
1.2 Market Segments
1.3 Key Spinal Muscular Atrophy Medicine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Spinal Muscular Atrophy Medicine Market Size Growth Rate by Type
1.4.2 LMI-070
1.4.3 ND-602
1.4.4 NT-1654
1.4.5 Nusinersen
1.4.6 NXD-30001
1.4.7 Others
1.5 Market by Application
1.5.1 Global Spinal Muscular Atrophy Medicine Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Spinal Muscular Atrophy Medicine Market Size, Estimates and Forecasts
2.1.1 Global Spinal Muscular Atrophy Medicine Revenue 2015-2026
2.1.2 Global Spinal Muscular Atrophy Medicine Sales 2015-2026
2.2 Global Spinal Muscular Atrophy Medicine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Spinal Muscular Atrophy Medicine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Spinal Muscular Atrophy Medicine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Spinal Muscular Atrophy Medicine Competitor Landscape by Players
3.1 Spinal Muscular Atrophy Medicine Sales by Manufacturers
3.1.1 Spinal Muscular Atrophy Medicine Sales by Manufacturers (2015-2020)
3.1.2 Spinal Muscular Atrophy Medicine Sales Market Share by Manufacturers (2015-2020)
3.2 Spinal Muscular Atrophy Medicine Revenue by Manufacturers
3.2.1 Spinal Muscular Atrophy Medicine Revenue by Manufacturers (2015-2020)
3.2.2 Spinal Muscular Atrophy Medicine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Spinal Muscular Atrophy Medicine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy Medicine Revenue in 2019
3.2.5 Global Spinal Muscular Atrophy Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Spinal Muscular Atrophy Medicine Price by Manufacturers
3.4 Spinal Muscular Atrophy Medicine Manufacturing Base Distribution, Product Types
3.4.1 Spinal Muscular Atrophy Medicine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Spinal Muscular Atrophy Medicine Product Type
3.4.3 Date of International Manufacturers Enter into Spinal Muscular Atrophy Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Spinal Muscular Atrophy Medicine Market Size by Type (2015-2020)
4.1.1 Global Spinal Muscular Atrophy Medicine Sales by Type (2015-2020)
4.1.2 Global Spinal Muscular Atrophy Medicine Revenue by Type (2015-2020)
4.1.3 Spinal Muscular Atrophy Medicine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Spinal Muscular Atrophy Medicine Market Size Forecast by Type (2021-2026)
4.2.1 Global Spinal Muscular Atrophy Medicine Sales Forecast by Type (2021-2026)
4.2.2 Global Spinal Muscular Atrophy Medicine Revenue Forecast by Type (2021-2026)
4.2.3 Spinal Muscular Atrophy Medicine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Spinal Muscular Atrophy Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Spinal Muscular Atrophy Medicine Market Size by Application (2015-2020)
5.1.1 Global Spinal Muscular Atrophy Medicine Sales by Application (2015-2020)
5.1.2 Global Spinal Muscular Atrophy Medicine Revenue by Application (2015-2020)
5.1.3 Spinal Muscular Atrophy Medicine Price by Application (2015-2020)
5.2 Spinal Muscular Atrophy Medicine Market Size Forecast by Application (2021-2026)
5.2.1 Global Spinal Muscular Atrophy Medicine Sales Forecast by Application (2021-2026)
5.2.2 Global Spinal Muscular Atrophy Medicine Revenue Forecast by Application (2021-2026)
5.2.3 Global Spinal Muscular Atrophy Medicine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Spinal Muscular Atrophy Medicine by Country
6.1.1 North America Spinal Muscular Atrophy Medicine Sales by Country
6.1.2 North America Spinal Muscular Atrophy Medicine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Spinal Muscular Atrophy Medicine Market Facts & Figures by Type
6.3 North America Spinal Muscular Atrophy Medicine Market Facts & Figures by Application
7 Europe
7.1 Europe Spinal Muscular Atrophy Medicine by Country
7.1.1 Europe Spinal Muscular Atrophy Medicine Sales by Country
7.1.2 Europe Spinal Muscular Atrophy Medicine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Spinal Muscular Atrophy Medicine Market Facts & Figures by Type
7.3 Europe Spinal Muscular Atrophy Medicine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Spinal Muscular Atrophy Medicine by Region
8.1.1 Asia Pacific Spinal Muscular Atrophy Medicine Sales by Region
8.1.2 Asia Pacific Spinal Muscular Atrophy Medicine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Spinal Muscular Atrophy Medicine Market Facts & Figures by Type
8.3 Asia Pacific Spinal Muscular Atrophy Medicine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Spinal Muscular Atrophy Medicine by Country
9.1.1 Latin America Spinal Muscular Atrophy Medicine Sales by Country
9.1.2 Latin America Spinal Muscular Atrophy Medicine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Spinal Muscular Atrophy Medicine Market Facts & Figures by Type
9.3 Central & South America Spinal Muscular Atrophy Medicine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Spinal Muscular Atrophy Medicine by Country
10.1.1 Middle East and Africa Spinal Muscular Atrophy Medicine Sales by Country
10.1.2 Middle East and Africa Spinal Muscular Atrophy Medicine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Spinal Muscular Atrophy Medicine Market Facts & Figures by Type
10.3 Middle East and Africa Spinal Muscular Atrophy Medicine Market Facts & Figures by Application
11 Company Profiles
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Corporation Information
11.1.2 Astellas Pharma Inc. Description and Business Overview
11.1.3 Astellas Pharma Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Products Offered
11.1.5 Astellas Pharma Inc. Related Developments
11.2 AveXis, Inc.
11.2.1 AveXis, Inc. Corporation Information
11.2.2 AveXis, Inc. Description and Business Overview
11.2.3 AveXis, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AveXis, Inc. Spinal Muscular Atrophy Medicine Products Offered
11.2.5 AveXis, Inc. Related Developments
11.3 Bioblast Pharma Ltd.
11.3.1 Bioblast Pharma Ltd. Corporation Information
11.3.2 Bioblast Pharma Ltd. Description and Business Overview
11.3.3 Bioblast Pharma Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Products Offered
11.3.5 Bioblast Pharma Ltd. Related Developments
11.4 Cytokinetics, Inc. 24
11.4.1 Cytokinetics, Inc. 24 Corporation Information
11.4.2 Cytokinetics, Inc. 24 Description and Business Overview
11.4.3 Cytokinetics, Inc. 24 Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Products Offered
11.4.5 Cytokinetics, Inc. 24 Related Developments
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.5.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Products Offered
11.5.5 F. Hoffmann-La Roche Ltd. Related Developments
11.6 Genethon
11.6.1 Genethon Corporation Information
11.6.2 Genethon Description and Business Overview
11.6.3 Genethon Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Genethon Spinal Muscular Atrophy Medicine Products Offered
11.6.5 Genethon Related Developments
11.7 Genzyme Corporation
11.7.1 Genzyme Corporation Corporation Information
11.7.2 Genzyme Corporation Description and Business Overview
11.7.3 Genzyme Corporation Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Genzyme Corporation Spinal Muscular Atrophy Medicine Products Offered
11.7.5 Genzyme Corporation Related Developments
11.8 GMP-Orphan SAS
11.8.1 GMP-Orphan SAS Corporation Information
11.8.2 GMP-Orphan SAS Description and Business Overview
11.8.3 GMP-Orphan SAS Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Products Offered
11.8.5 GMP-Orphan SAS Related Developments
11.9 Ionis Pharmaceuticals, Inc.
11.9.1 Ionis Pharmaceuticals, Inc. Corporation Information
11.9.2 Ionis Pharmaceuticals, Inc. Description and Business Overview
11.9.3 Ionis Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Products Offered
11.9.5 Ionis Pharmaceuticals, Inc. Related Developments
11.10 Longevity Biotech, Inc
11.10.1 Longevity Biotech, Inc Corporation Information
11.10.2 Longevity Biotech, Inc Description and Business Overview
11.10.3 Longevity Biotech, Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Products Offered
11.10.5 Longevity Biotech, Inc Related Developments
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Corporation Information
11.1.2 Astellas Pharma Inc. Description and Business Overview
11.1.3 Astellas Pharma Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Products Offered
11.1.5 Astellas Pharma Inc. Related Developments
11.12 Neurotune AG
11.12.1 Neurotune AG Corporation Information
11.12.2 Neurotune AG Description and Business Overview
11.12.3 Neurotune AG Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Neurotune AG Products Offered
11.12.5 Neurotune AG Related Developments
11.13 Novartis AG
11.13.1 Novartis AG Corporation Information
11.13.2 Novartis AG Description and Business Overview
11.13.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Novartis AG Products Offered
11.13.5 Novartis AG Related Developments
11.14 Sarepta Therapeutics, Inc.
11.14.1 Sarepta Therapeutics, Inc. Corporation Information
11.14.2 Sarepta Therapeutics, Inc. Description and Business Overview
11.14.3 Sarepta Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Sarepta Therapeutics, Inc. Products Offered
11.14.5 Sarepta Therapeutics, Inc. Related Developments
11.15 Voyager Therapeutics, Inc.
11.15.1 Voyager Therapeutics, Inc. Corporation Information
11.15.2 Voyager Therapeutics, Inc. Description and Business Overview
11.15.3 Voyager Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Voyager Therapeutics, Inc. Products Offered
11.15.5 Voyager Therapeutics, Inc. Related Developments
11.16 Vybion, Inc.
11.16.1 Vybion, Inc. Corporation Information
11.16.2 Vybion, Inc. Description and Business Overview
11.16.3 Vybion, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Vybion, Inc. Products Offered
11.16.5 Vybion, Inc. Related Developments
11.17 WAVE Life Sciences Ltd.
11.17.1 WAVE Life Sciences Ltd. Corporation Information
11.17.2 WAVE Life Sciences Ltd. Description and Business Overview
11.17.3 WAVE Life Sciences Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.17.4 WAVE Life Sciences Ltd. Products Offered
11.17.5 WAVE Life Sciences Ltd. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Spinal Muscular Atrophy Medicine Market Estimates and Projections by Region
12.1.1 Global Spinal Muscular Atrophy Medicine Sales Forecast by Regions 2021-2026
12.1.2 Global Spinal Muscular Atrophy Medicine Revenue Forecast by Regions 2021-2026
12.2 North America Spinal Muscular Atrophy Medicine Market Size Forecast (2021-2026)
12.2.1 North America: Spinal Muscular Atrophy Medicine Sales Forecast (2021-2026)
12.2.2 North America: Spinal Muscular Atrophy Medicine Revenue Forecast (2021-2026)
12.2.3 North America: Spinal Muscular Atrophy Medicine Market Size Forecast by Country (2021-2026)
12.3 Europe Spinal Muscular Atrophy Medicine Market Size Forecast (2021-2026)
12.3.1 Europe: Spinal Muscular Atrophy Medicine Sales Forecast (2021-2026)
12.3.2 Europe: Spinal Muscular Atrophy Medicine Revenue Forecast (2021-2026)
12.3.3 Europe: Spinal Muscular Atrophy Medicine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Spinal Muscular Atrophy Medicine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Spinal Muscular Atrophy Medicine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Spinal Muscular Atrophy Medicine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Spinal Muscular Atrophy Medicine Market Size Forecast by Region (2021-2026)
12.5 Latin America Spinal Muscular Atrophy Medicine Market Size Forecast (2021-2026)
12.5.1 Latin America: Spinal Muscular Atrophy Medicine Sales Forecast (2021-2026)
12.5.2 Latin America: Spinal Muscular Atrophy Medicine Revenue Forecast (2021-2026)
12.5.3 Latin America: Spinal Muscular Atrophy Medicine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Spinal Muscular Atrophy Medicine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Spinal Muscular Atrophy Medicine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Spinal Muscular Atrophy Medicine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Spinal Muscular Atrophy Medicine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Spinal Muscular Atrophy Medicine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Spinal Muscular Atrophy Medicine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Spinal Muscular Atrophy Medicine Market Segments
Table 2. Ranking of Global Top Spinal Muscular Atrophy Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Spinal Muscular Atrophy Medicine Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of LMI-070
Table 5. Major Manufacturers of ND-602
Table 6. Major Manufacturers of NT-1654
Table 7. Major Manufacturers of Nusinersen
Table 8. Major Manufacturers of NXD-30001
Table 9. Major Manufacturers of Others
Table 10. Global Spinal Muscular Atrophy Medicine Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Spinal Muscular Atrophy Medicine Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Spinal Muscular Atrophy Medicine Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Spinal Muscular Atrophy Medicine Sales Market Share by Regions (2015-2020)
Table 14. Global Spinal Muscular Atrophy Medicine Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Spinal Muscular Atrophy Medicine Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Spinal Muscular Atrophy Medicine Sales Share by Manufacturers (2015-2020)
Table 17. Global Spinal Muscular Atrophy Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Spinal Muscular Atrophy Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Muscular Atrophy Medicine as of 2019)
Table 19. Spinal Muscular Atrophy Medicine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Spinal Muscular Atrophy Medicine Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Spinal Muscular Atrophy Medicine Price (2015-2020) (USD/Pcs)
Table 22. Spinal Muscular Atrophy Medicine Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Spinal Muscular Atrophy Medicine Product Type
Table 24. Date of International Manufacturers Enter into Spinal Muscular Atrophy Medicine Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Spinal Muscular Atrophy Medicine Sales by Type (2015-2020) (K Pcs)
Table 27. Global Spinal Muscular Atrophy Medicine Sales Share by Type (2015-2020)
Table 28. Global Spinal Muscular Atrophy Medicine Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Spinal Muscular Atrophy Medicine Revenue Share by Type (2015-2020)
Table 30. Spinal Muscular Atrophy Medicine Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Spinal Muscular Atrophy Medicine Sales by Application (2015-2020) (K Pcs)
Table 32. Global Spinal Muscular Atrophy Medicine Sales Share by Application (2015-2020)
Table 33. North America Spinal Muscular Atrophy Medicine Sales by Country (2015-2020) (K Pcs)
Table 34. North America Spinal Muscular Atrophy Medicine Sales Market Share by Country (2015-2020)
Table 35. North America Spinal Muscular Atrophy Medicine Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Spinal Muscular Atrophy Medicine Revenue Market Share by Country (2015-2020)
Table 37. North America Spinal Muscular Atrophy Medicine Sales by Type (2015-2020) (K Pcs)
Table 38. North America Spinal Muscular Atrophy Medicine Sales Market Share by Type (2015-2020)
Table 39. North America Spinal Muscular Atrophy Medicine Sales by Application (2015-2020) (K Pcs)
Table 40. North America Spinal Muscular Atrophy Medicine Sales Market Share by Application (2015-2020)
Table 41. Europe Spinal Muscular Atrophy Medicine Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Spinal Muscular Atrophy Medicine Sales Market Share by Country (2015-2020)
Table 43. Europe Spinal Muscular Atrophy Medicine Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Spinal Muscular Atrophy Medicine Revenue Market Share by Country (2015-2020)
Table 45. Europe Spinal Muscular Atrophy Medicine Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Spinal Muscular Atrophy Medicine Sales Market Share by Type (2015-2020)
Table 47. Europe Spinal Muscular Atrophy Medicine Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Spinal Muscular Atrophy Medicine Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Spinal Muscular Atrophy Medicine Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Spinal Muscular Atrophy Medicine Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Spinal Muscular Atrophy Medicine Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Spinal Muscular Atrophy Medicine Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Spinal Muscular Atrophy Medicine Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Spinal Muscular Atrophy Medicine Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Spinal Muscular Atrophy Medicine Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Spinal Muscular Atrophy Medicine Sales Market Share by Application (2015-2020)
Table 57. Latin America Spinal Muscular Atrophy Medicine Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Spinal Muscular Atrophy Medicine Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Spinal Muscular Atrophy Medicine Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Spinal Muscular Atrophy Medicine Revenue Market Share by Country (2015-2020)
Table 61. Latin America Spinal Muscular Atrophy Medicine Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Spinal Muscular Atrophy Medicine Sales Market Share by Type (2015-2020)
Table 63. Latin America Spinal Muscular Atrophy Medicine Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Spinal Muscular Atrophy Medicine Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Spinal Muscular Atrophy Medicine Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Spinal Muscular Atrophy Medicine Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Spinal Muscular Atrophy Medicine Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Spinal Muscular Atrophy Medicine Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Spinal Muscular Atrophy Medicine Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Spinal Muscular Atrophy Medicine Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Spinal Muscular Atrophy Medicine Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Spinal Muscular Atrophy Medicine Sales Market Share by Application (2015-2020)
Table 73. Astellas Pharma Inc. Corporation Information
Table 74. Astellas Pharma Inc. Description and Major Businesses
Table 75. Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Astellas Pharma Inc. Product
Table 77. Astellas Pharma Inc. Recent Development
Table 78. AveXis, Inc. Corporation Information
Table 79. AveXis, Inc. Description and Major Businesses
Table 80. AveXis, Inc. Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. AveXis, Inc. Product
Table 82. AveXis, Inc. Recent Development
Table 83. Bioblast Pharma Ltd. Corporation Information
Table 84. Bioblast Pharma Ltd. Description and Major Businesses
Table 85. Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Bioblast Pharma Ltd. Product
Table 87. Bioblast Pharma Ltd. Recent Development
Table 88. Cytokinetics, Inc. 24 Corporation Information
Table 89. Cytokinetics, Inc. 24 Description and Major Businesses
Table 90. Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Cytokinetics, Inc. 24 Product
Table 92. Cytokinetics, Inc. 24 Recent Development
Table 93. F. Hoffmann-La Roche Ltd. Corporation Information
Table 94. F. Hoffmann-La Roche Ltd. Description and Major Businesses
Table 95. F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. F. Hoffmann-La Roche Ltd. Product
Table 97. F. Hoffmann-La Roche Ltd. Recent Development
Table 98. Genethon Corporation Information
Table 99. Genethon Description and Major Businesses
Table 100. Genethon Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Genethon Product
Table 102. Genethon Recent Development
Table 103. Genzyme Corporation Corporation Information
Table 104. Genzyme Corporation Description and Major Businesses
Table 105. Genzyme Corporation Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Genzyme Corporation Product
Table 107. Genzyme Corporation Recent Development
Table 108. GMP-Orphan SAS Corporation Information
Table 109. GMP-Orphan SAS Description and Major Businesses
Table 110. GMP-Orphan SAS Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. GMP-Orphan SAS Product
Table 112. GMP-Orphan SAS Recent Development
Table 113. Ionis Pharmaceuticals, Inc. Corporation Information
Table 114. Ionis Pharmaceuticals, Inc. Description and Major Businesses
Table 115. Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Ionis Pharmaceuticals, Inc. Product
Table 117. Ionis Pharmaceuticals, Inc. Recent Development
Table 118. Longevity Biotech, Inc Corporation Information
Table 119. Longevity Biotech, Inc Description and Major Businesses
Table 120. Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Longevity Biotech, Inc Product
Table 122. Longevity Biotech, Inc Recent Development
Table 123. Neurodyn Inc. Corporation Information
Table 124. Neurodyn Inc. Description and Major Businesses
Table 125. Neurodyn Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. Neurodyn Inc. Product
Table 127. Neurodyn Inc. Recent Development
Table 128. Neurotune AG Corporation Information
Table 129. Neurotune AG Description and Major Businesses
Table 130. Neurotune AG Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 131. Neurotune AG Product
Table 132. Neurotune AG Recent Development
Table 133. Novartis AG Corporation Information
Table 134. Novartis AG Description and Major Businesses
Table 135. Novartis AG Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 136. Novartis AG Product
Table 137. Novartis AG Recent Development
Table 138. Sarepta Therapeutics, Inc. Corporation Information
Table 139. Sarepta Therapeutics, Inc. Description and Major Businesses
Table 140. Sarepta Therapeutics, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 141. Sarepta Therapeutics, Inc. Product
Table 142. Sarepta Therapeutics, Inc. Recent Development
Table 143. Voyager Therapeutics, Inc. Corporation Information
Table 144. Voyager Therapeutics, Inc. Description and Major Businesses
Table 145. Voyager Therapeutics, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 146. Voyager Therapeutics, Inc. Product
Table 147. Voyager Therapeutics, Inc. Recent Development
Table 148. Vybion, Inc. Corporation Information
Table 149. Vybion, Inc. Description and Major Businesses
Table 150. Vybion, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 151. Vybion, Inc. Product
Table 152. Vybion, Inc. Recent Development
Table 153. WAVE Life Sciences Ltd. Corporation Information
Table 154. WAVE Life Sciences Ltd. Description and Major Businesses
Table 155. WAVE Life Sciences Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 156. WAVE Life Sciences Ltd. Product
Table 157. WAVE Life Sciences Ltd. Recent Development
Table 158. Global Spinal Muscular Atrophy Medicine Sales Forecast by Regions (2021-2026) (K Pcs)
Table 159. Global Spinal Muscular Atrophy Medicine Sales Market Share Forecast by Regions (2021-2026)
Table 160. Global Spinal Muscular Atrophy Medicine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 161. Global Spinal Muscular Atrophy Medicine Revenue Market Share Forecast by Regions (2021-2026)
Table 162. North America: Spinal Muscular Atrophy Medicine Sales Forecast by Country (2021-2026) (K Pcs)
Table 163. North America: Spinal Muscular Atrophy Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 164. Europe: Spinal Muscular Atrophy Medicine Sales Forecast by Country (2021-2026) (K Pcs)
Table 165. Europe: Spinal Muscular Atrophy Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 166. Asia Pacific: Spinal Muscular Atrophy Medicine Sales Forecast by Region (2021-2026) (K Pcs)
Table 167. Asia Pacific: Spinal Muscular Atrophy Medicine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 168. Latin America: Spinal Muscular Atrophy Medicine Sales Forecast by Country (2021-2026) (K Pcs)
Table 169. Latin America: Spinal Muscular Atrophy Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 170. Middle East and Africa: Spinal Muscular Atrophy Medicine Sales Forecast by Country (2021-2026) (K Pcs)
Table 171. Middle East and Africa: Spinal Muscular Atrophy Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 172. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 173. Key Challenges
Table 174. Market Risks
Table 175. Main Points Interviewed from Key Spinal Muscular Atrophy Medicine Players
Table 176. Spinal Muscular Atrophy Medicine Customers List
Table 177. Spinal Muscular Atrophy Medicine Distributors List
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Spinal Muscular Atrophy Medicine Product Picture
Figure 2. Global Spinal Muscular Atrophy Medicine Sales Market Share by Type in 2020 & 2026
Figure 3. LMI-070 Product Picture
Figure 4. ND-602 Product Picture
Figure 5. NT-1654 Product Picture
Figure 6. Nusinersen Product Picture
Figure 7. NXD-30001 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Spinal Muscular Atrophy Medicine Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Spinal Muscular Atrophy Medicine Report Years Considered
Figure 14. Global Spinal Muscular Atrophy Medicine Market Size 2015-2026 (US$ Million)
Figure 15. Global Spinal Muscular Atrophy Medicine Sales 2015-2026 (K Pcs)
Figure 16. Global Spinal Muscular Atrophy Medicine Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Spinal Muscular Atrophy Medicine Sales Market Share by Region (2015-2020)
Figure 18. Global Spinal Muscular Atrophy Medicine Sales Market Share by Region in 2019
Figure 19. Global Spinal Muscular Atrophy Medicine Revenue Market Share by Region (2015-2020)
Figure 20. Global Spinal Muscular Atrophy Medicine Revenue Market Share by Region in 2019
Figure 21. Global Spinal Muscular Atrophy Medicine Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy Medicine Revenue in 2019
Figure 23. Spinal Muscular Atrophy Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Spinal Muscular Atrophy Medicine Sales Market Share by Type (2015-2020)
Figure 25. Global Spinal Muscular Atrophy Medicine Sales Market Share by Type in 2019
Figure 26. Global Spinal Muscular Atrophy Medicine Revenue Market Share by Type (2015-2020)
Figure 27. Global Spinal Muscular Atrophy Medicine Revenue Market Share by Type in 2019
Figure 28. Global Spinal Muscular Atrophy Medicine Market Share by Price Range (2015-2020)
Figure 29. Global Spinal Muscular Atrophy Medicine Sales Market Share by Application (2015-2020)
Figure 30. Global Spinal Muscular Atrophy Medicine Sales Market Share by Application in 2019
Figure 31. Global Spinal Muscular Atrophy Medicine Revenue Market Share by Application (2015-2020)
Figure 32. Global Spinal Muscular Atrophy Medicine Revenue Market Share by Application in 2019
Figure 33. North America Spinal Muscular Atrophy Medicine Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Spinal Muscular Atrophy Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Spinal Muscular Atrophy Medicine Sales Market Share by Country in 2019
Figure 36. North America Spinal Muscular Atrophy Medicine Revenue Market Share by Country in 2019
Figure 37. U.S. Spinal Muscular Atrophy Medicine Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Spinal Muscular Atrophy Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Spinal Muscular Atrophy Medicine Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Spinal Muscular Atrophy Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Spinal Muscular Atrophy Medicine Market Share by Type in 2019

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs